Study Shows Link Between Diabetes Pill Actos And Bladder Cancer

Reuters reports that “taking Takeda Pharmaceutical’s diabetes drug Actos for more than two years doubles the risk of bladder cancer…A study by Canadian researchers found that Actos use of two years or more was associated with 88 extra cases of bladder cancer per 100,000 person years. This rose to 137 extra cases among patients who had taken more than 28,000 milligrams of the drug.”